Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Value chain stages
Value chain stages
Input
Products 21 to 30 of 120
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
BIO-SA Lubricant Additives and Base Stock
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
Canada
Country of distribution:
Canada
+
France
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:32 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
Biodata Tools/Medicine
by
Girihlet
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/28 16:57 (6 years ago)
Known funding amount:
250,000 USD
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
BioIsoprene
by
DuPont
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Biolon DDDA
by
Verdezyne
Biotech components:
Plant
Business models:
B2B
Country of production:
Malaysia
Country of distribution:
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:44 (6 years ago)
Known funding amount:
86,500,000 USD
Funding types:
Venture Capital
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
Biopolymer I6001
by
Yield10 Bioscience
+
Metabolix
Biotech components:
Bacteria
+
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:56 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Biopolymer I6003rp
by
Yield10 Bioscience
+
Metabolix
Biotech components:
Bacteria
+
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/01 09:56 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Biopolymer Mvera B5010 (Mirel)
by
Yield10 Bioscience
+
Metabolix
Biotech components:
Bacteria
+
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
Biopolymer Mvera B5011 (Mirel)
by
Yield10 Bioscience
+
Metabolix
Biotech components:
Bacteria
+
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
41,800,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
BSG005 for Systemic Fungal Infections
by
Biosergen ES
Biotech components:
Bacteria
Business models:
B2B
Country of production:
Norway
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
C3007
by
Yield10 Bioscience
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Open Release
Source:
Web search
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
1
2
3
4
5
6
7
8
9
10
…
12
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
